On the other hand, CSCs should not be clogged up by transporting every suspected stroke patient there, and primary stroke centers (PSCs) will have no experience administering tissue plasminogen activator (tPA) if they never receive stroke transports. The gene discussed is PLAT; the disease is stroke disorder.